Filing Flows › Haemonetics (HAE) › Free cash flow
Haemonetics (HAE) free cash flow by quarter
Haemonetics' free cash flow was $113M in Q2 FY27 (second quarter fiscal 2027), +190% from Q1 FY27. Over the last 7 quarters it ranged from $2.5M (Q1 FY26) to $113M (Q2 FY27).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q2 FY27 | $113M | +190% | +7% |
| Q1 FY27 | $39.1M | -27% | 16× |
| Q4 FY26 | $53.3M | -39% | -47% |
| Q3 FY26 | $87.2M | -18% | — |
| Q2 FY26 | $106M | 43× | — |
| Q1 FY26 | $2.5M | -98% | — |
| Q4 FY25 | $101M | — | — |
Q2 FY27 at a glance
Haemonetics, Q2 FY27: revenue $358M (+9% year over year), operating margin 21.0%, net earnings $46.3M, operating cash flow $128M. The chart follows the revenue to costs, profit and cash.
Questions
What is Haemonetics' free cash flow?
Haemonetics' free cash flow was $113M in Q2 FY27 (second quarter fiscal 2027), +190% from Q1 FY27.
How has Haemonetics' free cash flow changed?
Over the last 7 quarters it ranged from $2.5M (Q1 FY26) to $113M (Q2 FY27).